Prograf

Prograf prolongs the survival of the host and transplanted graft in animal transplant models of liver, kidney, heart, bone marrow, small bowel and pancreas, lung and trachea, skin, cornea, and limb.

Prograf is indicated for the prophylaxis of organ rejection in patients receiving allogeneic liver or kidney transplants.

prograf is indicated for the treatment of hypertension. In considering use of prograf, it should be noted that black patients receiving ACE inhibitors have been reported to have a higher incidence of angioedema compared to non-blacks.